Encoded Therapeutics Inc. logo

Encoded Therapeutics Inc. Funding & Investors

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.

encoded.com

Total Amount Raised: $239,100,000

Encoded Therapeutics Inc. Funding Rounds

  • Series D

    $135,000,000

    Series D Investors

    RTW Investments
    Illumina Ventures
    Menlo Ventures
    Nolan Capital
    SoftBank Investment Advisers
    Matrix Capital Management
    Arch Venture Partners
    Green Sands Equity
    GV
    Boxer Capital
    Meritech Capital Partners
    Farallon Capital Management
  • Series C

    $104,000,000

    Series C Investors

    RTW Investments
    Illumina Ventures
    Menlo Ventures
    Altitude Life Science Ventures
    Matrix Capital Management
    Venrock
    Arch Venture Partners
    Alexandria Venture Investments
    Boxer Capital
  • Convertible Note

    $100,000

    Convertible Note Investors

    Illumina Accelerator
Funding info provided by Diffbot.